# Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

> **NCT04806737** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 15 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** Teriflunomide Oral Tablet

## Key facts

- **NCT ID:** NCT04806737
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-16
- **Primary completion:** 2022-10-15
- **Final completion:** 2023-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04806737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04806737, "Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04806737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*